2nd Quarter Edition 2010

Sarah Terry Speaks at DCAT

MedTRACK is predicting mixed news for the healthcare industry in the wake of the March 23rd historic signing of the healthcare bill. These findings were presented by Sarah Terry, President of Life Science Analytics, in the PharmaChem Outlook 2010 report at the Drug, Chemical, and Associated Technologies (DCAT) meeting in New York City.

In the pharmaceutical industry, both branded and generic pharmaceuticals will experience volume growth as well as some hardships. Generics will face downward price pressures and later entry into the market. Reform measures will force branded pharmaceuticals to endure greater cost-containment pressures along with drug discounts. Pharma companies will also be bound by limitations on marketing practices.

Like last year's presentation, this year's report discusses the key trends shaping the future of our market space including:

•  Macro trends shaping the industry
•  Market drivers and growth areas
•  Strategies for future success
•  Who is positioned for success

If you are a subscriber to the database and would like to download a complimentary copy of the report, please click here. If you are currently not a subscriber and would like to receive a complimentary copy of the report, please click on the "Free Demo" tab located at the top of the page. After receiving a demonstration of the MedTRACK database, a copy of the report will be emailed to you.

Molecule Type Filter

A Molecule Type Filter in the Screener tool allows users to search active ingredients/products by molecule type (i.e. small molecule or large molecule). The molecule type will be included within the results column header for viewing the results.

Single vs. Combination Product Filter

A Single vs. Combination Product Filter has been created to refine product searches, based on single or multiple active ingredients. Saving the client time, it will help users look at specific results and easily determine single vs. combination products.

Worldwide Patent Project

Our Worldwide Patent Project is also continuing to move ahead and MedTRACK now contains patent information for phase III products, including biologics. A total of 8,805 patents have been added under this effort.

•  Product Type Filter (Branded vs. Generic drugs)
•  Release of worldwide patent data on products in Phase II of development
•  More robust Chemical Structure search capabilities
•  More extensive deals & alliances reporting
•  Enhanced Deal Data
•  Parent/Subsidiary Relationships

We are also moving full steam ahead on the new version of MedTRACK which is set to launch in early 2011! With a dynamic re-engineered architecture, MedTRACK's V2 will provide expanded product level information and a new look and feel. Included in the enhancements are proprietary datasets and decision support tools for enhanced analytics, trending, and forecasting. More updates to come...

Our MedTRACK team is attending the conferences listed below. For some of the conferences, we have filters available in MedTRACK to help delegates plan meetings and conduct due diligence. With one click, users can restrict their search results to only those companies.

Sarah Terry, President of Life Science Analytics, will be presenting at the upcoming Controlled Release Society Meeting in Portland, OR.

We look forward to seeing you there!